A Pilot Study of Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer After First-line Chemotherapy
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 14 Apr 2016
At a glance
- Drugs Lenalidomide (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 11 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 14 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Feb 2014 Planned initiation date changed from 1 Feb 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov.